1FUKUDA K.Opioids[M] ∥MILLER R D.Anesthesia.7th ed.Philadelphia:Churchill Livingstone,2010:769-824.
2ARMSTRONG S C,WYNN G H,SANDSON N B.Pharmacokinetic drug interactions of synthetic opiate analgesics[J].Psychosomatics,2009,50(2):169-176.
3PRASAD VERMA P R,CHANDAK A R.Development of matrix controlled transdermal delivery systems of pentazocine:In vitro/in vivo performance[J].Acta Pharm,2009,59(2):171-186.
4REISINE T,PASTERNAK G.Opioid analgesics and antagonists[M] ∥HARDMAN J G,GILMAN A G,LIMBIRD L E.Goodman and Gilman's The Pharmacological Basis of Therapeutics.9th ed.New York:Pergamon Press,1996:521-555.
5ZOLA Z M,MCLEOD D C.Comparative effects of analgesic efficacy of the agonist-antagonist opioids[J].Drug Intell Clin Pharm,1983,17(6):411-417.
8MARTIN W R,EADES C G,THOMPSON J A,et al.The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog[J].J Pharmacol Exp Ther,1976,197(3):517-532.
9BERKOWITZ B A,ASLING J H,SHNIDER S M,et al.Relationship of pentazocine plasma levels to pharmacological activity in man[J].Clin Pharm Ther,1969,10(3):320-328.
10GLIBERT P E,MARTIN W R.The effects of morphine-and nalorphine-like drugs in the nondependent,morphine-dependent and cyclazocine-dependent chronic spinal dog[J].J Pharmacol Exp Ther,1976,1989(1):66-82.
